Zobrazeno 1 - 10
of 17
pro vyhledávání: '"D, Lacruz Guzmán"'
Autor:
M.J. Morales Lara, C. Funes Vera, M Martínez Penella, V. Jorge Vidal, MC Mira Sirvent, D Lacruz Guzmán
Publikováno v:
Farmacia Hospitalaria. 32:280-285
Objective: To describe the use of bortezomib in a district hospital as an alternative in the treatment of malignant gammopathy. Methods: A retrospective analysis was carried out on patients treated with bortezomib in our hospital between November 200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a83ee31be1385ea106ea4623e8c392d
https://doi.org/10.1016/s1130-6343(08)75947-6
https://doi.org/10.1016/s1130-6343(08)75947-6
Autor:
M Martínez Penella, V. Jorge Vidal, M.J. Morales Lara, C. Funes Vera, D Lacruz Guzmán, MC Mira Sirvent
Publikováno v:
Farmacia Hospitalaria (English Edition). 32:280-285
Objective To describe the use of bortezomib in a district hospital as an alternative in the treatment of malignant gammopathy. Methods A retrospective analysis was carried out on patients treated with bortezomib in our hospital between November 2005
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c691780cc30a730ad6e59bfa805fc28
https://doi.org/10.1016/s2173-5085(08)70048-0
https://doi.org/10.1016/s2173-5085(08)70048-0
Autor:
A García Márquez, E Ferris Villanueva, Mdr Gutiérrez Cívicos, D Lacruz Guzmán, M Martínez Penella, R Guerrero Bautista, I Muñoz García, MH García Lagunar, V Alice Charlotte, AM Chica Marchal
Publikováno v:
European Journal of Hospital Pharmacy. 23:A35.3-A36
Background Oncology patients are susceptible to malnutrition and this is a risk factor for morbidity and mortality. Purpose To evaluate nutritional status in patients treated with oral chemotherapy in a tertiary hospital. Material and methods Prelimi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ae42ac14afbfb0a6ffc400ffbe5f753
https://doi.org/10.1136/ejhpharm-2016-000875.81
https://doi.org/10.1136/ejhpharm-2016-000875.81
Autor:
D, Lacruz Guzmán, C, Funes Vera, M, Martínez Penella, M J, Morales Lara, V, Jorge Vidal, M C, Mira Sirvent
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 32(5)
To describe the use of bortezomib in a district hospital as an alternative in the treatment of malignant gammopathy.A retrospective analysis was carried out on patients treated with bortezomib in our hospital between November 2005 and October 2007. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c8294020a5960b5dc9b90f369f93e14b
https://pubmed.ncbi.nlm.nih.gov/19150043
https://pubmed.ncbi.nlm.nih.gov/19150043
Autor:
A García Márquez, García Simón, M Gutiérrez Cívicos, D Lacruz Guzmán, R Guerrero Bautista, Álvarez Álvarez, I Muñoz García, MH García Lagunar, M Martínez Penella, E Ferris Villanueva
Publikováno v:
European Journal of Hospital Pharmacy. 22:A13.1-A13
Background Behcet’s disease (BD) is a rheumatic disease characterised by polyarthritis, urogenital ulcers, uveitis, cutaneous lesions, alterations in the central nervous system and vascular disease. Purpose To describe the use of adalimumab in a pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ab78e7c60f86de4aa6509ae6ba6e0a0
https://doi.org/10.1136/ejhpharm-2015-000639.30
https://doi.org/10.1136/ejhpharm-2015-000639.30
Autor:
R Guerrero Bautista, AM Chica Marchal, MH García Lagunar, García Simón, A García Márquez, I Muñoz García, M Martínez Penella, Mdr Gutiérrez Cívicos, E Ferris Villanueva, D Lacruz Guzmán
Publikováno v:
European Journal of Hospital Pharmacy. 22:A13.2-A14
Background The use of drugs during pregnancy is always controversial. There is limited information about the use of infliximab during pregnancy. Purpose To describe the effectiveness and safety of infliximab in a patient with ankylosing spondylitis d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62dd04ef33f8dd28561c9c34de731098
https://doi.org/10.1136/ejhpharm-2015-000639.31
https://doi.org/10.1136/ejhpharm-2015-000639.31
Autor:
E Ferris Villanueva, A García Márquez, M Gutiérrez Cívicos, I Español Morales, MH García Lagunar, D Lacruz Guzmán, R Guerrero Bautista, M Martínez Penella, I Muñoz García, García Simón
Publikováno v:
European Journal of Hospital Pharmacy. 22:A32.1-A32
Background Idiopathic thrombocytopenic purpura (ITP) is a disease characterised by decreased platelet count. Romiplostim and eltrombopag are thrombopoietin receptor agonists (TRAs) that stimulate platelet production. Purpose To evaluate the effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0a257ab36e96c5145fb0ab480caa22b
https://doi.org/10.1136/ejhpharm-2015-000639.76
https://doi.org/10.1136/ejhpharm-2015-000639.76
Autor:
D Lacruz Guzmán, M Martínez Penella, R Guerrero Bautista, V Dominguez Leñero, E Ferris Villanueva, P Pérez Cañadas, M de Andrés Bautista, H Garcia Lagunar
Publikováno v:
European Journal of Hospital Pharmacy. 20:A131.1-A131
Background Anti-TNF drugs show high inter-individual variability in efficacy and toxicity. Currently there are no genetic, biochemical or environmental markers to predict response to treatment. Purpose To assess the influence of gene polymorphism rs2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62b586323d60808731d4ec8f54f2ac3b
https://doi.org/10.1136/ejhpharm-2013-000276.362
https://doi.org/10.1136/ejhpharm-2013-000276.362
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.